10 Výsledek
FIELD OF THE INVENTION
This invention is directed to a method and composition useful for the preventative and curative treatment of exercise induced pulmonary hemorrhage in animals. More particularly, this invention relates to the health management of animal populations and to a method and
TECHNICAL FIELD
The present invention relates to a superficial cerebral vascular bleeding inhibitor having an effect of inhibiting bleeding from superficial cerebral blood vessels during intracranial surgery and the like in the field of neurosurgery, and to a packaged container containing the
The present invention relates to a dental hemostatic composition. More particularly, it relates to a hemostatic composition for local application to small hemorrhage in the dental field.
An aqueous solution or dispersion containing 10 to 40 w/v% of an astringent, such as tannic acid, aluminum
CROSS-REFERENCE TO RELATED APPLICATIONS
Not applicable
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to hemostatic products, and particularly to the
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not applicable
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates generally to hemostatic products, and particularly to the
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISC
Not applicable
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates generally to hemostatic products, and particularly to the
This application is a U.S. continuation-in-part of International Application No. PCT/US94/04816, with an International Filing Date of May 11, 1994.
FIELD OF THE INVENTION
The present invention is directed to a method for preventing and treating exercise-induced pulmonary hemorrhage (EIPH) in
FIELD OF THE INVENTION
The present invention relates to a novel diazabicycloalkene compound having excellent potassium channel opening activity and to treating agents for hypertension, angina pectoris, and asthma which contain the diazabicycloalkene compound as an active ingredient.
BACKGROUND OF
A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by any one of the patent disclosure, as it appears in the Patent & Trademark Office patent files or records, but